TEORA  
 

TEORA > Høgskolen i Telemark > Fakultet for allmennvitenskapelige fag > Institutt for natur-, helse- og miljøvernfag >

English Norsk

Denne identifikatoren kan du bruke til å sitere eller lenke til denne innførselen: http://hdl.handle.net/2282/671

Tilhørende filer:

Fil Beskrivelse StørrelseFormat
Expression_of_NDRG2.pdf513.56 kBAdobe PDFÅpne
Tittel: Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Forfattere: Lorentzen, Anders
Vogel, Lotte K.
Lewinsky, Rikke H.
Sæbø, Mona
Skjelbred, Camilla Furu
Godiksen, Sine
Hoff, Geir
Lothe, Inger Marie Bowitz
Ikdahl, Tone
Kure, Elin H.
Mitchelmore, Cathy
Dato: 12-Oct-2007
Forlagets versjon: http://dx.doi.org/10.1186/1471-2407-7-192
Sammendrag: BACKGROUND: It has recently been shown that NDRG2 mRNA is down-regulated or undetectable in several human cancers and cancer cell-lines. Although the function of NDRG2 is unknown, high NDRG2 expression correlates with improved prognosis in high-grade gliomas. The aim of this study has been to examine NDRG2 mRNA expression in colon cancer. By examining affected and normal tissue from individuals with colorectal adenomas and carcinomas, as well as in healthy individuals, we aim to determine whether and at which stages NDRG2 down-regulation occurs during colonic carcinogenesis. METHODS: Using quantitative RT-PCR, we have determined the mRNA levels for NDRG2 in low-risk (n = 15) and high-risk adenomas (n = 57), colorectal carcinomas (n = 50) and corresponding normal tissue, as well as control tissue from healthy individuals (n = 15). NDRG2 levels were normalised to β-actin. RESULTS: NDRG2 mRNA levels were lower in colorectal carcinomas compared to normal tissue from the control group (p < 0.001). When comparing adenomas/carcinomas with adjacent normal tissue from the same individual, NDRG2 expression levels were significantly reduced in both high-risk adenoma (p < 0.001) and in colorectal carcinoma (p < 0.001). There was a trend for NDRG2 levels to decrease with increasing Dukes' stage (p < 0.05). CONCLUSION: Our results demonstrate that expression of NDRG2 is down-regulated at a late stage during colorectal carcinogensis. Future studies are needed to address whether NDRG2 down-regulation is a cause or consequence of the progression of colorectal adenomas to carcinoma.
Nøkkelord: Colorectal cancer
Adenoma
Carcinoma
Genetics
Forlag: BioMed Central
Dokumenttype: Journal article
URI: http://hdl.handle.net/2282/671
Vises i samlingene:Medisinsk genetikk
Onkologi
Institutt for natur-, helse- og miljøvernfag

Denne innførselen er lisensiert under en brukslisens. Alle innførsler i TEORA er beskyttet av opphavsrett.

 

TEORA bygger på DSpace 1.4
Høgskolen i Telemark har alle rettigheter til denne siden
Høgskolen i Telemark, Biblioteket, Postboks 203, 3901 Porsgrunn
Telefon: 35952543, E-post: teora@hit.no
Webmaster: Arild Skalmeraas
Teknisk ansvarlig: Rune Pettersen
Ansvarlig redaktør: Biblioteksjef Frode Bakken